Real-time enrollment status for this glioblastoma clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 2:01 PM UTC
| NCT Number | NCT06556563 |
| Recruiting Status | Recruiting |
| Condition | Glioblastoma |
| Phase | Clinical Trial |
| Target Enrollment | 741 participants |
| Active Locations | 29 sites in the US |
| Sponsor | NovoCure GmbH |
| Last Updated on CT.gov | February 4, 2026 (3 weeks ago) |
As of March 2, 2026: Clinical trial NCT06556563 is currently recruiting participants. This clinical trial study for glioblastoma is actively seeking new participants at 29 locations across the United States. The study is sponsored by NovoCure GmbH. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06556563 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 29 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06556563 was last updated 3 weeks ago (February 4, 2026). HelloStudys verifies this status automatically.